Product NDC: | 0143-9933 |
Proprietary Name: | Cefotaxime |
Non Proprietary Name: | Cefotaxime |
Active Ingredient(s): | 2 g/1 & nbsp; Cefotaxime |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0143-9933 |
Labeler Name: | West-ward Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065071 |
Marketing Category: | ANDA |
Start Marketing Date: | 20021120 |
Package NDC: | 0143-9933-25 |
Package Description: | 25 VIAL in 1 PACKAGE (0143-9933-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9933-01) |
NDC Code | 0143-9933-25 |
Proprietary Name | Cefotaxime |
Package Description | 25 VIAL in 1 PACKAGE (0143-9933-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9933-01) |
Product NDC | 0143-9933 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefotaxime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20021120 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp |
Substance Name | CEFOTAXIME SODIUM |
Strength Number | 2 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |